Trevi Therapeutics (TRVI) Other Non Operating Income (2021 - 2025)
Trevi Therapeutics' quarterly Other Non Operating Income came in at -$15000.0 in Q4 2025, down 850.0% year-on-year from $2000.0 in Q4 2024, and down 650.0% quarter-over-quarter from -$2000.0 in Q3 2025.
Trevi Therapeutics has reported Other Non Operating Income for 5 years, with the latest figure at -$15000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income fell 850.0% year-over-year to -$15000.0; the trailing twelve-month figure through Dec 2025 stood at -$22000.0 (down 46.67% YoY), and the FY2025 full-year result was -$31000.0, down 106.67% from the prior year.
- Other Non Operating Income for Q4 2025 stood at -$15000.0, down from -$2000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $165000.0 in Q1 2023, with the low at -$404000.0 in Q4 2021.
- Average Other Non Operating Income over 5 years is -$5411.8, with a median of -$5000.0 recorded in 2021.
- Year-over-year, Other Non Operating Income soared 1600.0% in 2023 and tumbled 850.0% in 2025.
- Tracing TRVI's Other Non Operating Income over 5 years: stood at -$404000.0 in 2021, then surged by 66.34% to -$136000.0 in 2022, then surged by 97.79% to -$3000.0 in 2023, then jumped by 166.67% to $2000.0 in 2024, then plunged by 850.0% to -$15000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$15000.0 (Q4 2025), -$2000.0 (Q3 2025), and -$7000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | 154,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Mar 31, 2023 | 165,000.00 |
| Jun 30, 2022 | -136,000.00 |
| Mar 31, 2022 | -11,000.00 |
| Dec 31, 2021 | -404,000.00 |
| Sep 30, 2021 | -5,000.00 |
| Jun 30, 2021 | 40,000.00 |
| Mar 31, 2021 | -6,000.00 |